LIF, but Not IL‐6, Regulates Osteoprogenitor Differentiation in Rat Calvaria Cell Cultures: Modulation by Dexamethasone

Cytokines of the interleukin 6 (IL‐6) subfamily are a group of factors produced by osteoblasts and acting through the same transducing element, membrane protein gp130. We have previously shown that exogenous (added to the culture medium) leukemia inhibitory factor (LIF) inhibits bone nodule formation and expression of osteoblast‐associated genes in fetal rat calvaria (RC) cell cultures and that dexamethasone (Dex) increases the ID50 of LIF. To investigate the respective roles of IL‐6–related cytokines and receptors in osteprogenitor differentiation, and their regulatory interplay with Dex, we used reverse transcribed polymerase chain reaction, bioassay, and blocking antibody techniques to assess the time courses of LIF, IL‐6, LIF transmembrane receptor, IL‐6 receptor, and gp130 expression in RC cell cultures grown with and without Dex. The levels of the mRNAs for IL‐6, LIF, and gp130 decreased concomitantly with the formation of bone nodules. Dex treatment, which stimulates bone nodule formation, reduced the expression of LIF and IL‐6 mRNAs and IL‐6 bioactivity in the culture medium. LIF treatment strongly stimulated the expression of IL‐6. Incubation with anti‐LIF antibodies increased the number of nodules, while an antibody blocking IL‐6 activity had little or no effect on nodule numbers and did not antagonize the action of exogenous LIF, indicating that IL‐6 does not mediate the action of LIF in this system. Moreover, although exogenously added IL‐6 was active in the cultures as noted by a reduction of nodule mineralization, it had no effect on nodule numbers, i.e., on osteoprogenitor differentiation, in the presence or absence of Dex. In conclusion, IL‐6, LIF, and their receptors are expressed throughout the time‐course of osteogenesis in RC cell cultures. However, only LIF, but not IL‐6, appears to play a significant role in autocrine regulation of osteoblastic differentiation in this system. The antagonist action of Dex on the effects of exogenously added LIF, as well as the bone‐promoting action of Dex in RC cell cultures, could be exerted partly through the down‐regulation of the expression of endogenous LIF.

[1]  M. Centrella,et al.  Oncostatin-M: a new bone active cytokine that activates osteoblasts and inhibits bone resorption. , 1996, Endocrinology.

[2]  A I Caplan,et al.  Cytokine expression by human marrow‐derived mesenchymal progenitor cells in vitro: Effects of dexamethasone and IL‐1α , 1996, Journal of cellular physiology.

[3]  G. Yancopoulos,et al.  Detection of receptors for interleukin-6, interleukin-11, leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor in bone marrow stromal/osteoblastic cells. , 1996, The Journal of clinical investigation.

[4]  J. Reiffers,et al.  In vitro biosynthesis of leukemia inhibitory factor/human interleukin for DA cells by human endothelial cells: differential regulation by interleukin-1 alpha and glucocorticoids. , 1995, Blood.

[5]  T. Martin,et al.  Interleukin (IL)-6 induction of osteoclast differentiation depends on IL-6 receptors expressed on osteoblastic cells but not on osteoclast progenitors , 1995, The Journal of experimental medicine.

[6]  H. Haugen,et al.  Developmental abnormalities in mice transgenic for bovine oncostatin M , 1995, Molecular and cellular biology.

[7]  J. Aubin,et al.  Leukemia inhibitory factor inhibits osteogenic differentiation in rat calvaria cell cultures. , 1995, Endocrinology.

[8]  R. Jilka,et al.  Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. , 1995, The New England journal of medicine.

[9]  J. Aubin,et al.  Dexamethasone alters the subpopulation make‐up of rat bone marrow stromal cell cultures , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[10]  P. Heinrich,et al.  Soluble receptors for cytokines and growth factors: generation and biological function. , 1994, The Biochemical journal.

[11]  G. Passeri,et al.  Interleukin-11: a new cytokine critical for osteoclast development. , 1994, The Journal of clinical investigation.

[12]  Y. Yamamoto‐Yamaguchi,et al.  Three different cDNAs encoding mouse D-factor/LIF receptor. , 1994, Journal of biochemistry.

[13]  J. Uhl,et al.  Hydrocortisone regulation of interleukin-6 protein production by a purified population of human peripheral blood monocytes. , 1993, Clinical immunology and immunopathology.

[14]  G. Yancopoulos,et al.  Soluble forms of the interleukin-6 signal-transducing receptor component gp130 in human serum possessing a potential to inhibit signals through membrane-anchored gp130. , 1993, Blood.

[15]  F. Hughes,et al.  Interleukin-6 inhibits bone formation in vitro. , 1993, Bone and mineral.

[16]  P. Villiger,et al.  Induction of cytokine expression by leukemia inhibitory factor. , 1993, The Journal of clinical investigation.

[17]  I. Reid,et al.  The effect of leukemia inhibitory factor on bone in vivo. , 1993, Endocrinology.

[18]  L. D. Ward,et al.  A major binding protein for leukemia inhibitory factor in normal mouse serum: identification as a soluble form of the cellular receptor. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[19]  M. Hibi,et al.  Molecular cloning of a murine IL-6 receptor-associated signal transducer, gp130, and its regulated expression in vivo. , 1992, Journal of immunology.

[20]  G. Ciliberto,et al.  Expression of the murine interleukin 6 receptor in hepatoma cells: the intracytoplasmic domain is not required for interleukin 6 signal transduction , 1992, European journal of immunology.

[21]  J. Aubin,et al.  Positive and negative immunoselection for enrichment of two classes of osteoprogenitor cells , 1991, The Journal of cell biology.

[22]  J. Aubin,et al.  Initiation and progression of mineralization of bone nodules formed in vitro: the role of alkaline phosphatase and organic phosphate. , 1991, Bone and mineral.

[23]  T. Hirano,et al.  IL-6 is produced by osteoblasts and induces bone resorption. , 1990, Journal of immunology.

[24]  Austin G Smith,et al.  Differentiation inhibiting activity is produced in matrix-associated and diffusible forms that are generated by alternate promoter usage , 1990, Cell.

[25]  J. Renauld,et al.  Materials and Methods Briefdefinitive Report , 2022 .

[26]  T. Willson,et al.  Structural organization of the genes for murine and human leukemia inhibitory factor. Evolutionary conservation of coding and non-coding regions. , 1990, The Journal of biological chemistry.

[27]  M. Hattori,et al.  Structure of the rat interleukin 6 gene and its expression in macrophage-derived cells. , 1989, The Journal of biological chemistry.

[28]  D. Gearing,et al.  Fatal syndrome in mice engrafted with cells producing high levels of the leukemia inhibitory factor. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[29]  S. Akira,et al.  Genomic structure of the murine IL-6 gene. High degree conservation of potential regulatory sequences between mouse and human. , 1988, Journal of immunology.

[30]  J. Aubin,et al.  Physiological concentrations of glucocorticoids stimulate formation of bone nodules from isolated rat calvaria cells in vitro. , 1987, Endocrinology.

[31]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[32]  Ray Monk,et al.  Mammals have multiple genes for individual ribosomal proteins , 1981, Cell.

[33]  D. Brunette,et al.  Parathyroid Hormone- and Prostaglandin E1-Response in a Selected Population of Bone Cells After Repeated Subculture and Storage at ‒80 C , 1977 .

[34]  M. Zaidi.  Molecular and cellular biology of bone , 1998 .

[35]  R. Brattsand,et al.  Cytokine modulation by glucocorticoids: mechanisms and actions in cellular studies. , 1996, Alimentary pharmacology & therapeutics.

[36]  J. Aubin,et al.  OSTEOBLASTIC CELL LINEAGE , 1993 .

[37]  I. Reid,et al.  Leukaemia inhibitory factor and bone cell function. , 1992, Ciba Foundation symposium.

[38]  M. Fey,et al.  Glucocorticoids downregulate gene expression of GM-CSF, NAP-1/IL-8, and IL-6, but not of M-CSF in human fibroblasts. , 1992, Blood.

[39]  P. Patterson,et al.  Further studies of the distribution of CDF/LIF mRNA. , 1992, Ciba Foundation symposium.

[40]  S. Schröder,et al.  The MTT-assay as a rapid test for cell proliferation and cell killing: application to human peripheral blood lymphocytes (PBL). , 1991, Allergie und Immunologie.

[41]  J. Aubin,et al.  Ultrastructural analysis of bone nodules formed in vitro by isolated fetal rat calvaria cells. , 1988, Bone.